There were no significant differences between the parenteral group and the enteral group in the mean number of treated infectious complications ( @ vs. @ ; P = @ ) , @-day mortality ( @ of @ patients -LSB- @ % -RSB- vs. @ of @ patients -LSB- @ % -RSB- , P = @ ) , in rates of @ other secondary outcomes , or in rates of adverse events .